Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Farmers Insurance
Chinese Patent Office
Accenture
Teva
QuintilesIMS

Generated: June 17, 2019

DrugPatentWatch Database Preview

Levodopa - Generic Drug Details

« Back to Dashboard

What are the generic sources for levodopa and what is the scope of levodopa patent protection?

Levodopa is the generic ingredient in four branded drugs marketed by Valeant Pharm Intl, Shire, Roche, and Acorda, and is included in four NDAs. There are eighteen patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Levodopa has one hundred and forty-one patent family members in twenty-six countries.

There are eighteen drug master file entries for levodopa. One supplier is listed for this compound.

Summary for levodopa
Pharmacology for levodopa
Medical Subject Heading (MeSH) Categories for levodopa
Synonyms for levodopa
.beta.-(3, 4-Dihydroxyphenyl)alanine
.beta.-(3,4-Dihydroxyphenyl)-L-alanine
.beta.-(3,4-Dihydroxyphenyl)alanine
(-)-(3,4-Dihydroxyphenyl)alanine
(-)-3-(3,4-Dihydroxyphenyl)-L-alanine
(-)-Dopa
(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate
(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid
(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acidL-dopa
(S)-2-Amino-3-(3,4-dihydroxy-phenyl)-propionic acid
(S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid
(S)-3,4-dihydroxyphenylalanine
13173-EP2269989A1
13173-EP2277876A1
13173-EP2277882A1
13173-EP2281559A1
13173-EP2281815A1
13173-EP2292614A1
13173-EP2295412A1
13173-EP2295413A1
13173-EP2295439A1
13173-EP2298731A1
13173-EP2301933A1
13173-EP2301934A1
13173-EP2305633A1
13173-EP2305640A2
13173-EP2308867A2
13173-EP2308870A2
13173-EP2311827A1
13173-EP2311837A1
13173-EP2314571A2
13173-EP2316470A2
13173-EP2316834A1
1E83F927-C221-46AA-B90A-81B33C5F3868
21660-EP2272832A1
21660-EP2275420A1
21660-EP2281559A1
21660-EP2301934A1
21660-EP2314571A2
21920-EP2295410A1
21920-EP2301939A1
21920-EP2314571A2
23734-74-9
25525-15-9
3-(3,4-Dihydroxyphenyl)-L-alanine
3-(3,4-Dihydroxyphenyl)-L-alanine, 99%
3-(3,4-Dihydroxyphenyl)-L-alanine; L-3-Hydroxytyrosine; L-DOPA; Levodopa
3-Hydroxy-L-tyrosine
3, 4-Dihydroxy-L-phenylalanine
3, 4-Dihydroxyphenylalanine
3,4-dihydroxy-L-phenylalanine
3,4-Dihydroxy-L-phenylalanine, >=98% (TLC)
3,4-Dihydroxy-L-phenylalanine, certified reference material, TraceCERT(R)
3,4-Dihydroxy-L-phenylalanine, Vetec(TM) reagent grade, 98%
3,4-Dihydroxyphenyl-L-alanine
3,4-Dihydroxyphenylalanine
3,4-Dihydroxyphenylalanine (VAN)
34241-25-3
46627O600J
587-45-1
59-92-7
59L927
72572-99-7
72573-00-3
88250-23-1
90638-38-3
AB00052418_08
AB00052418_09
AB00052418-06
AB00052418-07
AB0013279
AB1009504
AC-8432
AC1L1LOR
AC1Q4U7F
AJ-24154
AK187821
AKOS010396267
Alanine, 3-(3, 4-dihydroxyphenyl)-, (-)-
Alanine, 3-(3,4-dihydroxyphenyl)-
Alanine, 3-(3,4-dihydroxyphenyl)-, (-)-
alanine, 3-(3,4-dihydroxyphenyl)-, L-
Alanine,4-dihydroxyphenyl)-
Alanine,4-dihydroxyphenyl)-, (-)-
Alanine,4-dihydroxyphenyl)-, L-
AM82124
AN-1108
ANW-33396
AS-13287
b-(3,4-Dihydroxyphenyl)-a-L-alanine
b-(3,4-Dihydroxyphenyl)-L-alanine
b-(3,4-Dihydroxyphenyl)alanine
BC677906
BDBM50130192
BDBM60928
Bendopa
beta-(3,4-Dihydroxyphenyl)-alpha-alanine
beta-(3,4-Dihydroxyphenyl)-alpha-L-alanine
beta-(3,4-Dihydroxyphenyl)-L-alanine
beta-(3,4-Dihydroxyphenyl)alanine
BIDD:GT0158
Biodopa
bmse000322
BP-12850
BPBio1_000059
Brocadopa
BSPBio_000053
BSPBio_002354
C00355
C9H11NO4
CAS-59-92-7
CCG-39571
CCRIS 3766
Cerepap
CHEBI:15765
CHEMBL1009
Cidandopa
component of Sinemet
CS-1945
CTK1H2187
CVT-301
D 9628
D00059
D0600
D9628
DB01235
Deadopa
Dihydroxy-L-phenylalanine
dihydroxyphenylalanine
DivK1c_000452
Dopa
Dopaflex
Dopaidan
Dopal-fher
Dopalina
Dopar
Dopar (TN)
Doparkine
Doparl
Dopasol
Dopaston
Dopaston SE
Dopastone
Dopastral
Dopicar
Doprin
DSSTox_CID_3209
DSSTox_GSID_23209
DSSTox_RID_76926
DTXSID9023209
EINECS 200-445-2
Eldopal
Eldopar
Eldopatec
Epitope ID:150927
EU-0100454
Eurodopa
F0347-4695
FT-0603250
GTPL3639
H813
Helfo DOPA
Helfo-Dopa
HMS1568C15
HMS1922J14
HMS2090O08
HMS2093N04
HMS2095C15
HMS2230B04
HMS3261K10
HMS3712C15
HMS501G14
HSDB 3348
HY-N0304
I01-10387
IDI1_000452
Inbrija
Inbrija (levodopa inhalation powder)
Insulamina
IV Levodopa
J10404
KB-28327
KBio1_000452
KBio2_000934
KBio2_003502
KBio2_006070
KBioGR_001177
KBioSS_000934
KM0355
L Dopa
L-.beta.-(3,4-Dihydroxyphenyl)alanine
L-(-)-Dopa
L-(3, 4-Dihydroxyphenyl)-.alpha.-alanine
L-(3, 4-Dihydroxyphenyl)alanine
L-(3,4-Dihydroxyphenyl)-.alpha.-alanine
L-(3,4-Dihydroxyphenyl)alanine
L-(o-Dihydroxyphenyl)alanine
L-3-(3,4-dihydroxy-phenyl)alanine
L-3-(3,4-dihydroxyphenyl)-Alanine
L-3-(3,4-Dihydroxyphenyl)alanine
L-3-(3,4-Dihydroxyphenyl)alanine(L-DOPA )
L-3-Hydroxytyrosine
L-3,4-Dihydrophenylalanine
L-3,4-Dihydroxyphenylalanine
L-4-5-Dihydroxyphenylalanine
L-b-(3,4-Dihydroxyphenyl)-a-alanine
L-beta-(3,4-Dihydroxyphenyl)-alpha-alanine
L-beta-(3,4-Dihydroxyphenyl)alanine
L-Dihydroxyphenylalanine
L-dopa
L-Dopa, L-3-Hydroxytyrosine
L-DOPA; Levodopa
L-O-Dihydroxyphenylalanine
L-o-Hydroxytyrosine
L-Tyrosine, 3-hydroxy-
L(-)-Dopa
Laradopa
Larodopa
Ledopa
Levedopa
Levodopa (JP15/USP)
Levodopa (JP17/USP/INN)
Levodopa (Sinemet)
Levodopa [USAN:INN:BAN:JAN]
Levodopa [USAN:USP:INN:BAN:JAN]
Levodopa, British Pharmacopoeia (BP) Reference Standard
Levodopa, European Pharmacopoeia (EP) Reference Standard
Levodopa, Pharmaceutical Secondary Standard; Certified Reference Material
Levodopa, United States Pharmacopeia (USP) Reference Standard
Levodopum
Levodopum [INN-Latin]
Levopa
Lopac-D-9628
Lopac0_000454
LP00454
LS-255
Madopa (Salt/Mix)
Maipedopa
MCULE-4743781842
MFCD00002598
MLS000028514
MolPort-000-856-937
N1648
NCGC00015384-01
NCGC00016270-01
NCGC00016270-04
NCGC00016270-06
NCGC00016270-07
NCGC00016270-09
NCGC00016270-10
NCGC00093869-04
NCGC00261139-01
NINDS_000452
NSC 118381
NSC-118381
NSC-759573
NSC118381
NSC759573
Parda
Pardopa
PDSP1_001541
PDSP2_001525
Pharmakon1600-02300205
Prestwick_185
Prestwick0_000017
Prestwick1_000017
Prestwick2_000017
Prestwick3_000017
Prodopa
Prolopa
Q-201294
Ro 4-6316
RTR-020755
s1726
SBB017533
SBI-0050439.P003
SC-10704
SCHEMBL22655
SDCCGMLS-0066924.P001
SMR000058312
Sobiodopa
SPBio_000391
SPBio_001974
Spectrum_000454
Spectrum2_000496
SPECTRUM2300205
Spectrum4_000539
Spectrum5_001899
SR-01000075384
SR-01000075384-1
SR-01000075384-4
SR-01000075384-6
SR-01000075384-7
ST086623
Syndopa
Tox21_110338
Tox21_500454
TR-020755
Tyrosine, 3-hydroxy-
UNII-46627O600J
UNII-QI9C343R60 component WTDRDQBEARUVNC-LURJTMIESA-N
VA11170
Veldopa
Weldopa
WLN: QVYZ1R CQ DQ
WLN: QVYZ1R CQ DQ -L
WTDRDQBEARUVNC-LURJTMIESA-N
Z1762772338
ZINC895199

US Patents and Regulatory Information for levodopa

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Shire DOPAR levodopa CAPSULE;ORAL 016913-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Acorda INBRIJA levodopa POWDER;INHALATION 209184-001 Dec 21, 2018 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Acorda INBRIJA levodopa POWDER;INHALATION 209184-001 Dec 21, 2018 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Roche LARODOPA levodopa TABLET;ORAL 016912-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Shire DOPAR levodopa CAPSULE;ORAL 016913-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Acorda INBRIJA levodopa POWDER;INHALATION 209184-001 Dec 21, 2018 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Acorda INBRIJA levodopa POWDER;INHALATION 209184-001 Dec 21, 2018 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for levodopa

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1613296 CR 2015 00042 Denmark ➤ Sign Up PRODUCT NAME: KOMBINATION AF SAFINAMID, HERUNDER SAFINAMID METHANSULFONAT, OG LEVODOPA/PDI; REG. NO/DATE: EU/1/14/984/001-010 20150226
1613296 92782 Luxembourg ➤ Sign Up PRODUCT NAME: SAFINAMIDE A UTILISER EN COMBINAISON AVEC LEVODOPA/PDI, ET EVENTUELLEMENT AVEC D'AUTRES MEDICAMENTS PD , POUR LE TRAITEMENT DE LA MALADIE DE PARKINSON; FIRST REGISTRATION DATE: 20150224
Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
Argus Health
Fish and Richardson
Moodys
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.